{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:04:54Z","timestamp":1788206694117,"version":"build-2803163510"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0213192","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T14:11:59Z","timestamp":1551967919000},"page":"e0213192","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1460-7535","authenticated-orcid":true,"given":"Min","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-2375","authenticated-orcid":true,"given":"Meg J.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-7620","authenticated-orcid":true,"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Pilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4975-9793","authenticated-orcid":true,"given":"Laurent","family":"Billot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5497-4298","authenticated-orcid":true,"given":"Kris","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"J Lv","year":"2013","journal-title":"CMAJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials","volume":"347","author":"T Ninomiya","year":"2013","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"MR Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"LF Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.1750","article-title":"Enhanced large intestinal potassium permeability in end-stage renal disease","volume":"206","author":"T Mathialahan","year":"2005","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines","volume":"158","author":"CG Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e005428","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin\u2013angiotensin system blockade: The Stockholm Creatinine Measurements (SCREAM) Project","volume":"6","author":"G Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ekir.2017.07.001","article-title":"Serum potassium levels and risk of sudden cardiac death among patients with chronic kidney disease and significant coronary artery disease","volume":"2","author":"PH Pun","year":"2017","journal-title":"Kidney In Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"LM Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic","volume":"7","author":"PA Sarafidis","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1470320313507122","article-title":"The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia","volume":"15","author":"JH Lee","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref12","unstructured":"NPS MedicineWise: MedicineInsight Databook. 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/cdn1.scrvt.com\/08ab3606b0b7a8ea53fd0b40b1c44f86\/aff5c32a15ffb684\/2039c6e3ad50\/MedicineInsight-Databook-v1.2.pdf\" xlink:type=\"simple\">https:\/\/cdn1.scrvt.com\/08ab3606b0b7a8ea53fd0b40b1c44f86\/aff5c32a15ffb684\/2039c6e3ad50\/MedicineInsight-Databook-v1.2.pdf<\/ext-link> (accessed 13 November 2017 2017)."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref14","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"ref15","article-title":"Remoteness Structure","volume":"Volume 5","year":"2016"},{"key":"ref16","unstructured":"Australian Bureau of Statistics: 2011. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/2033.0.55.001\" xlink:type=\"simple\">http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/2033.0.55.001<\/ext-link> (accessed Mar 26 2018)."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/HYPERTENSIONAHA.116.07363","article-title":"Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System","volume":"67","author":"AR Chang","year":"2016","journal-title":"Hypertension"},{"key":"ref18","article-title":"Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes\u2014a Danish population-based cohort study","author":"RW Thomsen","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function","volume":"11","author":"J Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/HYPERTENSIONAHA.111.180554","article-title":"Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"59","author":"MH Alderman","year":"2012","journal-title":"Hypertension"},{"key":"ref21","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"M Epstein","year":"2015","journal-title":"Am J Manag Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0213192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:18:31Z","timestamp":1588961911000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0213192"}},"subtitle":[],"editor":[{"given":"Patrick Barry","family":"Mark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0213192","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]}}}